![Tobias Reich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tobias Reich
Directeur/Membre du Conseil chez
BIOFRONTERA AG
Profil
Tobias Reich currently works at ConBrio Beteiligungen AG, as Director and Biofrontera AG, as Member-Supervisory Board.
Mr. Reich also formerly worked at One Equity Partners Europe GmbH, as Managing Director from 2002 to 2015, Smartrac NV, as Member-Supervisory Board from 2011 to 2013, and CornerstoneCapital Verwaltungs AG, as Partner from 2016 to 2018.
Postes actifs de Tobias Reich
| Sociétés | Poste | Début |
|---|---|---|
| BIOFRONTERA AG | Directeur/Membre du Conseil | - |
ConBrio Beteiligungen AG | Directeur/Membre du Conseil | - |
Anciens postes connus de Tobias Reich
| Sociétés | Poste | Fin |
|---|---|---|
CornerstoneCapital Verwaltungs AG
 CornerstoneCapital Verwaltungs AG Investment ManagersFinance CornerstoneCapital is an active manager which invests in profitable, technology-related growth companies in Germany, Switzerland and Austria in the engineering/chemical, software, medical technology and business services sectors. For growth capital investments, they take minority stakes, seeking to invest EUR 2-7 million in companies with sales greater than EUR 5 million and a unique technology or service. The firm prefers to take majority ownership positions with co-investors for their MBO investments, seeking to invest EUR 5-50 million (more than EUR 50 million with co-investors) in companies with sales greater than EUR 10 million, preferably with a dominant position in a niche market. CornerstoneCapital takes minority stakes in their private investments in public entities, seeking to invest EUR 5-10 million (up to EUR 30 million with co-investors) in listed companies with sales of at least EUR 20 million. The firm's partners focus on a few selected investments, co-investing personal money alongside their fund, seeking to invest in companies with a technological product or process advantage in a growing market, sustainable barriers to entry and potential for market leadership. They partner with investee management, providing support including strategy specification, recruitment of complementary management resources as well as M&A and finance activities. CornerstoneCapital's investment team makes the firm's investment decisions. They typically hold an investment for three to seven years, working with management to determine the optimal timing and the best route to exit in order to maximize value, usually through trade sales and IPOs. | Private Equity Investor | 30/11/2018 |
One Equity Partners Europe GmbH
 One Equity Partners Europe GmbH Investment ManagersFinance Acts as an alternative investment manager | Private Equity Investor | 31/01/2015 |
Smartrac NV
 Smartrac NV Electronic Production EquipmentElectronic Technology Develops, manufactures and supplies RFID and NFC transponders and inlays | Directeur/Membre du Conseil | 22/01/2013 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Smartrac NV
Smartrac NV Electronic Production EquipmentElectronic Technology Develops, manufactures and supplies RFID and NFC transponders and inlays | Electronic Technology |
CornerstoneCapital Verwaltungs AG
CornerstoneCapital Verwaltungs AG Investment ManagersFinance CornerstoneCapital is an active manager which invests in profitable, technology-related growth companies in Germany, Switzerland and Austria in the engineering/chemical, software, medical technology and business services sectors. For growth capital investments, they take minority stakes, seeking to invest EUR 2-7 million in companies with sales greater than EUR 5 million and a unique technology or service. The firm prefers to take majority ownership positions with co-investors for their MBO investments, seeking to invest EUR 5-50 million (more than EUR 50 million with co-investors) in companies with sales greater than EUR 10 million, preferably with a dominant position in a niche market. CornerstoneCapital takes minority stakes in their private investments in public entities, seeking to invest EUR 5-10 million (up to EUR 30 million with co-investors) in listed companies with sales of at least EUR 20 million. The firm's partners focus on a few selected investments, co-investing personal money alongside their fund, seeking to invest in companies with a technological product or process advantage in a growing market, sustainable barriers to entry and potential for market leadership. They partner with investee management, providing support including strategy specification, recruitment of complementary management resources as well as M&A and finance activities. CornerstoneCapital's investment team makes the firm's investment decisions. They typically hold an investment for three to seven years, working with management to determine the optimal timing and the best route to exit in order to maximize value, usually through trade sales and IPOs. | Finance |
Biofrontera AG
 Biofrontera AG Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops and distributes dermatological products | Health Technology |
One Equity Partners Europe GmbH
One Equity Partners Europe GmbH Investment ManagersFinance Acts as an alternative investment manager | Finance |
ConBrio Beteiligungen AG |
